Transport augmentation through the blood-inner ear barriers of guinea pigs treated with 3-nitropropionic acid and patients with acute hearing loss, visualized with 3.0 T MRI

Otology and Neurotology

Volumn 32, Issue 2, 2011, Pages 204-212

  Zou, Jing ^a   Li, Meng ^a   Zhang, Ya ^b   Zheng, Guiliang ^a   Chen, Donghui ^a   Chen, Shiyue ^a   Zheng, Hongliang ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF TAMPERE MEDICAL SCHOOL   (Finland)

Author keywords

Acute inner ear disease; Biological barrier; Contrast agent; Magnetic resonance imaging; Mitochondria; Permeability

Indexed keywords

3 NITROPROPIONIC ACID; 3-NITROPROPIONIC ACID; CONTRAST MEDIUM; DNA; GADOLINIUM PENTETATE; NITRO DERIVATIVE; PROPIONIC ACID DERIVATIVE;

ADULT; ANIMAL; ARTICLE; AUDIOMETRY; AUDITORY THRESHOLD; CASE REPORT; COCHLEA; DNA FRAGMENTATION; FEMALE; GENETICS; GUINEA PIG; HUMAN; INNER EAR; METABOLISM; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PERCEPTION DEAFNESS; PHYSIOLOGY; VESTIBULAR TEST;

ADULT; ANIMALS; AUDIOMETRY; AUDITORY THRESHOLD; COCHLEA; CONTRAST MEDIA; DNA; DNA FRAGMENTATION; EAR, INNER; FEMALE; GADOLINIUM DTPA; GUINEA PIGS; HEARING LOSS, SENSORINEURAL; HUMANS; MAGNETIC RESONANCE IMAGING; NITRO COMPOUNDS; PROPIONIC ACIDS; VESTIBULAR FUNCTION TESTS;

EID: 79955661108     PISSN: 15317129     EISSN: 15374505     Source Type: Journal    
DOI: 10.1097/MAO.0b013e3182016332     Document Type: Article

References (39)

1. Gussen R. Sudden deafness of vascular origin: a human temporal bone study. Ann Otol Rhinol Laryngol 1976; 85: 94-100.
2. Mosnier I, Stepanian A, Baron G, et al. Cardiovascular and thrombo-embolic risk factors in idiopathic sudden sensorineural hearing loss: a case-control study. Audiol Neurootol 2010; 16: 55-66.
3. Schreiber BE, Agrup C, Haskard DO, et al. Sudden sensorineural hearing loss. Lancet 2010; 375: 1203-11.
4. Toubi E, Ben-David J, Kessel A, et al. Immune-mediated disorders associated with idiopathic sudden sensorineural hearing loss. Ann Otol Rhinol Laryngol 2004; 113: 445-9.
5. Merchant SN, Adams JC, Nadol JB Jr. Pathology and pathophysiology of idiopathic sudden sensorineural hearing loss. Otol Neurotol 2005; 26: 151-60.
6. Hyde GE, Rubel EW. Mitochondrial role in hair cell survival after injury. Otolaryngol Head Neck Surg 1995; 113: 530-40.
7. Berrettini S, Forli F, Siciliano G, et al. Sudden bilateral hearing loss and sporadic mitochondrial DNA deletion. J Laryngol Otol 2001; 115: 128-31.
8. Dehne N, Rauen U, de Groot H, et al. Involvement of the mitochondrial permeability transition in gentamicin ototoxicity. Hear Res 2002; 169: 47-55.
9. Vicente-Torres MA, Schacht J. A BAD link to mitochondrial cell death in the cochlea of mice with noise-induced hearing loss. J Neurosci Res 2006; 83: 1564-72.
10. Rybak LP, Ramkumar V. Ototoxicity. Kidney Int 2007; 72: 931-5.
11. Hoya N, Okamoto Y, Kamiya K, et al. A novel animal model of acute cochlear mitochondrial dysfunction. Neuroreport 2004; 15: 1597-600.
12. Hallpike CS, Cairns H. Observations on the pathology of Meniere's syndrome: (section of otology). Proc R Soc Med 1938; 31: 1317-36.
13. Paparella MM. The cause (multifactorial inheritance) and pathogenesis (endolymphatic malabsorption) of Meniere's disease and its symptoms (mechanical and chemical). Acta Otolaryngol 1985; 99: 445-51.
14. Rauch SD, San Martin JE, Moscicki RA, et al. Serum antibodies against heat shock protein 70 in Meniere's disease. Am J Otol 1995; 16: 648-52.
15. Lee KS, Kimura RS. Ischemia of the endolymphatic sac. Acta Otolaryngol 1992; 112: 658-66.
16. Welling DB, Daniels RL, Brainard J, et al. Detection of viral DNA in endolymphatic sac tissue from Meniere's disease patients. Am J Otol 1994; 15: 639-43.
17. Selmani Z, Marttila T, Pyykko I. Incidence of virus infection as a cause of Meniere's disease or endolymphatic hydrops assessed by electrocochleography. Eur Arch Otorhinolaryngol 2005; 262: 331-4.
18. Pyykko I, Zou J. Do viruses cause inner ear disturbances? ORL J Otorhinolaryngol Relat Spec 2008; 70: 32-40; discussion-1.
19. Dunnebier EA, Segenhout JM, Dijk F, et al. Cochlear ultrastructure in two-phase endolymphatic hydrops in the guinea-pig. Eur Arch Otorhinolaryngol 2002; 259: 17-23.
20. Sakagami M, Tomiyama S, Fukazawa K, et al. Vascular permeability of the stria vascularis and morphology of the endolymphatic sac in two types of experimental endolymphatic hydrops. Ann Otol Rhinol Laryngol 1995; 104: 210-7.
21. Danckwardt-Lilliestrom N, Friberg U, Kinnefors A, et al. "Endolymphatic sacitis" in a case of active Meniere's disease. An ultrastructural histopathologic investigation. Ann Otol Rhinol Laryngol 1997; 106: 190-8.
22. Zou J, Börje B, Bretlau P, Tayamaga T. Endolymphatic hydrops is caused by increased porosity of stria vascularis? Paper presented at Barany Society Meeting. Uppsala, Sweden, 2000.
23. Zou J, Pyykko I, Bretlau P, et al. In vivo visualization of endolymphatic hydrops in guinea pigs: magnetic resonance imaging evaluation at 4.7 Tesla. Ann Otol Rhinol Laryngol 2003; 112: 1059-65.
24. Zou J, Börje B, Toppila E. In vivo MRI visualization of endolymphatic hydrops induced by keyhole limpet hemocyanin round window immunization. Audiol Med 2007; 5: 182-7.
25. Zou J, Poe D, Bjelke B, et al. Visualization of inner ear disorders with MRI in vivo: from animal models to human application. Acta Otolaryngol 2009: 22-31.
26. Marshall AF, Jewells VL, Kranz P, et al. Magnetic resonance imaging of guinea pig cochlea after vasopressin-induced or surgically induced endolymphatic hydrops. Otolaryngol Head Neck Surg 2010; 142: 260-5.
27. Mark AS, Seltzer S, Nelson-Drake J, et al. Labyrinthine enhancement on gadolinium-enhanced magnetic resonance imaging in sudden deafness and vertigo: correlation with audiologic and electronystagmographic studies. Ann Otol Rhinol Laryngol 1992; 101: 459-64.
28. Naganawa S, Koshikawa T, Nakamura T, et al. High-resolution T1-weighted 3D real IR imaging of the temporal bone using tripledose contrast material. Eur Radiol 2003; 13: 2650-8.
29. Naganawa S, Komada T, Fukatsu H, et al. Observation of contrast enhancement in the cochlear fluid space of healthy subjects using a 3D-FLAIR sequence at 3 Tesla. Eur Radiol 2006; 16: 733-7.
30. Tagaya M, Teranishi M, Naganawa S, et al. 3 Tesla magnetic resonance imaging obtained 4 hours after intravenous gadolinium injection in patients with sudden deafness. Acta Otolaryngol 2010; 130: 665-9.
31. Zou J, Zhang W, Poe D, et al. Differential passage of gadolinium through the mouse inner ear barriers evaluated with 4.7T MRI. Hearing Res 2010; 259: 36-43.
32. Zou J, Pyykko I, Bjelke B, et al. Communication between the perilymphatic scalae and spiral ligament visualized by in vivo MRI. Audiol Neurootol 2005; 10: 145-52.
33. Duan M, Bjelke B, Fridberger A, et al. Imaging of the guinea pig cochlea following round window gadolinium application. Neuroreport 2004; 15: 1927-30.
34. Nakashima T, Naganawa S, Sugiura M, et al. Visualization of endolymphatic hydrops in patients with Meniere's disease. Laryngoscope 2007; 117: 415-20.
35. WMA Declaration of Helsinki - Ethical Principles for Medical Re-search Involving Human Subjects. World Medical Association, 2008. Available at: http://www.wma.net/en/30publications/10policies/b3/index.html.
36. Counter SA, Bjelke B, Borg E, et al. Magnetic resonance imaging of the membranous labyrinth during in vivo gadolinium (Gd-DTPA-BMA) uptake in the normal and lesioned cochlea. Neuroreport 2000; 11: 3979-83.
37. Zou J, Pyykko I, Counter SA, et al. In vivo observation of dynamic perilymph formation using 4.7 T MRI with gadolinium as a tracer. Acta Otolaryngol 2003; 123: 910-5.
38. Nakamura T, Naganawa S, Fukatsu H, et al. Contrast enhancement of the cochlear aqueduct in MR imaging: its frequency and clinical significance. Neuroradiology 2003; 45: 626-30.
39. Tanigawa T, Tanaka H, Sato T, et al. 3D-FLAIR MRI findings in patients with low-tone sudden deafness. Acta Otolaryngol 2010. [Epub ahead of print].